DE602004021394D1 - Indol-6-sulfonamid-derivate, ihre herstellung und ihre verwendung als 5-ht-6 modulatoren - Google Patents
Indol-6-sulfonamid-derivate, ihre herstellung und ihre verwendung als 5-ht-6 modulatorenInfo
- Publication number
- DE602004021394D1 DE602004021394D1 DE602004021394T DE602004021394T DE602004021394D1 DE 602004021394 D1 DE602004021394 D1 DE 602004021394D1 DE 602004021394 T DE602004021394 T DE 602004021394T DE 602004021394 T DE602004021394 T DE 602004021394T DE 602004021394 D1 DE602004021394 D1 DE 602004021394D1
- Authority
- DE
- Germany
- Prior art keywords
- indol
- modulators
- preparation
- sulfonamide derivatives
- sulfonamide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- AFJYOUBTIAOUQI-UHFFFAOYSA-N 1h-indole-6-sulfonamide Chemical class NS(=O)(=O)C1=CC=C2C=CNC2=C1 AFJYOUBTIAOUQI-UHFFFAOYSA-N 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A61K31/4045—Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
- C07D209/42—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/08—Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Diabetes (AREA)
- Psychiatry (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Endocrinology (AREA)
- Psychology (AREA)
- Epidemiology (AREA)
- Child & Adolescent Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Pain & Pain Management (AREA)
- Gynecology & Obstetrics (AREA)
- Reproductive Health (AREA)
- Emergency Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Indole Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ES200301810A ES2222832B1 (es) | 2003-07-30 | 2003-07-30 | Derivados de 6-indolilsulfonamidas, su preparacion y su aplicacion como medicamentos. |
| PCT/EP2004/008510 WO2005013976A1 (en) | 2003-07-30 | 2004-07-29 | Indol-6 sulfonamide derivatives, their preparation and their use 5-ht-6 as modulators |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE602004021394D1 true DE602004021394D1 (de) | 2009-07-16 |
Family
ID=34130544
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE602004021394T Active DE602004021394D1 (de) | 2003-07-30 | 2004-07-29 | Indol-6-sulfonamid-derivate, ihre herstellung und ihre verwendung als 5-ht-6 modulatoren |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US7462640B2 (de) |
| EP (1) | EP1660077B1 (de) |
| JP (1) | JP2007500164A (de) |
| KR (1) | KR20060123699A (de) |
| CN (1) | CN100563650C (de) |
| AR (1) | AR045155A1 (de) |
| AT (1) | ATE432701T1 (de) |
| AU (1) | AU2004262484A1 (de) |
| BR (1) | BRPI0413112A (de) |
| CA (1) | CA2533970A1 (de) |
| DE (1) | DE602004021394D1 (de) |
| ES (2) | ES2222832B1 (de) |
| IL (1) | IL172894A0 (de) |
| MX (1) | MXPA06001141A (de) |
| NO (1) | NO20060682L (de) |
| NZ (1) | NZ545301A (de) |
| PE (1) | PE20050280A1 (de) |
| PT (1) | PT1660077E (de) |
| RU (1) | RU2006105777A (de) |
| TW (1) | TW200509907A (de) |
| WO (1) | WO2005013976A1 (de) |
| ZA (1) | ZA200600419B (de) |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2222832B1 (es) | 2003-07-30 | 2006-02-16 | Laboratorios Del Dr. Esteve, S.A. | Derivados de 6-indolilsulfonamidas, su preparacion y su aplicacion como medicamentos. |
| US7781478B2 (en) | 2004-07-14 | 2010-08-24 | Ptc Therapeutics, Inc. | Methods for treating hepatitis C |
| US8013006B2 (en) | 2004-07-14 | 2011-09-06 | Ptc Therapeutics, Inc. | Methods for treating hepatitis C |
| ES2246721B1 (es) * | 2004-08-10 | 2007-03-16 | Laboratorios Del Dr. Esteve, S.A. | Compuestos indolicos sustituidos, su preparacion y su uso como medicamentos. |
| EP1632491A1 (de) * | 2004-08-30 | 2006-03-08 | Laboratorios Del Dr. Esteve, S.A. | Substituierte indol-verbindungen und deren verwendung als modulatoren des 5-ht6 rezeptors |
| WO2007024944A1 (en) * | 2005-08-25 | 2007-03-01 | Schering Corporation | Imidazole derivatives as functionally selective alpha2c adrenoreceptor agonists |
| JP4912414B2 (ja) * | 2006-01-24 | 2012-04-11 | イーライ リリー アンド カンパニー | インドールスルホンアミド系のプロゲステロン受容体調節物質 |
| EP1953153A1 (de) * | 2007-01-31 | 2008-08-06 | Laboratorios del Dr. Esteve S.A. | Heterocyclyl-substituierte Sulfonamide für die Behandlung von Wahrnehmungsstörungen bzw. Ernährungserkrankungen |
| DE102007007751A1 (de) * | 2007-02-16 | 2008-08-21 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Neue substituierte Arylsulfonylglycine, deren Herstellung und deren Verwendung als Arzneimittel |
| DE102007012284A1 (de) | 2007-03-16 | 2008-09-18 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Neue substituierte Arylsulfonylglycine, deren Herstellung und deren Verwendung als Arzneimittel |
| EP2018861A1 (de) * | 2007-07-26 | 2009-01-28 | Laboratorios del Dr. Esteve S.A. | 5HT6-Liganden wie Sulfonamidederivaten bei wirkstoffinduzierter Gewichtszunahme |
| DE102007035334A1 (de) * | 2007-07-27 | 2009-01-29 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Neue substituierte Arylsulfonylglycine, deren Herstellung und deren Verwendung als Arzneimittel |
| DE102007035333A1 (de) * | 2007-07-27 | 2009-01-29 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Neue substituierte Arylsulfonylglycine, deren Herstellung und deren Verwendung als Arzneimittel |
| ES2358288T3 (es) | 2007-08-01 | 2011-05-09 | Laboratorios Del Dr. Esteve S.A. | Combinación de al menos dos ligandos de 5ht6. |
| DE102007042154A1 (de) | 2007-09-05 | 2009-03-12 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Arylsulfonylaminomethyphosphonsäure-Derivate, deren Herstellung und deren Verwendung als Arzneimittel |
| EP2053052A1 (de) | 2007-10-23 | 2009-04-29 | Laboratorios del Dr. Esteve S.A. | Verfahren zur Herstellung von 6-substituiertem Imidazo[2,1-b]thiazol-5-sulfonylhalogenid |
| EP2116547A1 (de) * | 2008-05-09 | 2009-11-11 | Laboratorios Del. Dr. Esteve, S.A. | Substituierte n-Imidazo[2,1-b]thiazol-5-sulfonamid-Derivative als 5-TH6-Liganden |
| ES2562083T3 (es) | 2008-06-06 | 2016-03-02 | Neurmedix, Inc. | Métodos para preparar 17-alquinil-7-hidroxi-esteroides y compuestos relacionados |
| ITMC20080120A1 (it) * | 2008-06-20 | 2009-12-21 | Nazario Luzi | Sistema di ripresa video in particolare per la pesca. |
| EP2149573A1 (de) * | 2008-08-01 | 2010-02-03 | Laboratorios Del. Dr. Esteve, S.A. | Substituierte Indolsulfonamidverbindungen, ihre Herstellung und ihre Verwendung als Medikamente |
| US20190336585A1 (en) * | 2018-05-03 | 2019-11-07 | John Lawrence Mee | Method for sustainable human cognitive enhancement |
| US20190390193A1 (en) * | 2018-06-23 | 2019-12-26 | John Lawrence Mee | Reversible method for sustainable human cognitive enhancement |
| CA3115472A1 (en) | 2018-10-05 | 2020-04-09 | Annapurna Bio, Inc. | Compounds and compositions for treating conditions associated with apj receptor activity |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3472870A (en) * | 1966-08-29 | 1969-10-14 | Mead Johnson & Co | Sulfonamidotryptamines |
| WO1995032967A1 (en) | 1994-05-28 | 1995-12-07 | Smithkline Beecham Plc | Amide derivatives having 5ht1d-antagonist activity |
| CZ288897A3 (cs) | 1995-03-20 | 1998-02-18 | Eli Lilly And Company | V poloze 5-substituovaný 3-(1,2,3,6-tetrahydropyridin-4-yl)indol a 3-(piperidin-4-yl)indol a farmaceutický prostředek, který je obsahuje |
| DE19625184B4 (de) | 1996-06-24 | 2005-06-30 | Wabag Wassertechnik Gmbh | Verfahren zur Aufbereitung von Prozeßwasser aus einer Flaschenreinigungsmaschine |
| US5939451A (en) * | 1996-06-28 | 1999-08-17 | Hoffmann-La Roche Inc. | Use of sulfonamides |
| DE19753522A1 (de) * | 1997-12-03 | 1999-06-10 | Boehringer Ingelheim Pharma | Substituierte Indole, ihre Herstellung und ihre Verwendung als Arzneimittel |
| GB9926302D0 (en) | 1999-11-05 | 2000-01-12 | Smithkline Beecham Plc | Novel compounds |
| US6995162B2 (en) | 2001-01-12 | 2006-02-07 | Amgen Inc. | Substituted alkylamine derivatives and methods of use |
| WO2002060871A2 (en) | 2001-01-30 | 2002-08-08 | Eli Lilly And Company | Benzenesulfonic acid indol-5-yl esters as antagonists of the 5-ht6 receptor |
| ES2187300B1 (es) * | 2001-11-14 | 2004-06-16 | Laboratorios Del Dr. Esteve, S.A. | Derivados de sulfonamidas, su preparacion y su aplicacion como medicamentos. |
| ES2313002T3 (es) * | 2003-05-09 | 2009-03-01 | Laboratorios Del Dr. Esteve, S.A. | Uso de derivados de sulfonamida para la fabricacion de un medicamento para la profilaxis y/o tratamiento de la ingestion de alimentos. |
| EP1666378A4 (de) * | 2003-06-02 | 2007-10-17 | Marifit Kk | Behälterverbindungsbefestigungsvorrichtung aus metall |
| ES2222832B1 (es) | 2003-07-30 | 2006-02-16 | Laboratorios Del Dr. Esteve, S.A. | Derivados de 6-indolilsulfonamidas, su preparacion y su aplicacion como medicamentos. |
-
2003
- 2003-07-30 ES ES200301810A patent/ES2222832B1/es not_active Expired - Fee Related
-
2004
- 2004-07-29 AT AT04741319T patent/ATE432701T1/de not_active IP Right Cessation
- 2004-07-29 US US10/566,101 patent/US7462640B2/en not_active Expired - Fee Related
- 2004-07-29 EP EP04741319A patent/EP1660077B1/de active Active
- 2004-07-29 WO PCT/EP2004/008510 patent/WO2005013976A1/en active Application Filing
- 2004-07-29 ZA ZA200600419A patent/ZA200600419B/en unknown
- 2004-07-29 CN CNB2004800222711A patent/CN100563650C/zh not_active Expired - Fee Related
- 2004-07-29 KR KR1020067001738A patent/KR20060123699A/ko not_active Application Discontinuation
- 2004-07-29 AR ARP040102697A patent/AR045155A1/es unknown
- 2004-07-29 NZ NZ545301A patent/NZ545301A/en unknown
- 2004-07-29 PT PT04741319T patent/PT1660077E/pt unknown
- 2004-07-29 MX MXPA06001141A patent/MXPA06001141A/es active IP Right Grant
- 2004-07-29 TW TW093122667A patent/TW200509907A/zh unknown
- 2004-07-29 ES ES04741319T patent/ES2327845T3/es active Active
- 2004-07-29 DE DE602004021394T patent/DE602004021394D1/de active Active
- 2004-07-29 AU AU2004262484A patent/AU2004262484A1/en not_active Abandoned
- 2004-07-29 JP JP2006521528A patent/JP2007500164A/ja active Pending
- 2004-07-29 RU RU2006105777/04A patent/RU2006105777A/ru unknown
- 2004-07-29 BR BRPI0413112-6A patent/BRPI0413112A/pt not_active IP Right Cessation
- 2004-07-29 CA CA002533970A patent/CA2533970A1/en not_active Abandoned
- 2004-08-02 PE PE2004000735A patent/PE20050280A1/es not_active Application Discontinuation
-
2005
- 2005-12-29 IL IL172894A patent/IL172894A0/en unknown
-
2006
- 2006-02-10 NO NO20060682A patent/NO20060682L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| TW200509907A (en) | 2005-03-16 |
| PE20050280A1 (es) | 2005-06-12 |
| EP1660077A1 (de) | 2006-05-31 |
| AU2004262484A1 (en) | 2005-02-17 |
| CN1832738A (zh) | 2006-09-13 |
| BRPI0413112A (pt) | 2006-10-03 |
| PT1660077E (pt) | 2009-09-03 |
| EP1660077B1 (de) | 2009-06-03 |
| KR20060123699A (ko) | 2006-12-04 |
| CN100563650C (zh) | 2009-12-02 |
| MXPA06001141A (es) | 2006-04-24 |
| ZA200600419B (en) | 2007-03-28 |
| AR045155A1 (es) | 2005-10-19 |
| JP2007500164A (ja) | 2007-01-11 |
| WO2005013976A1 (en) | 2005-02-17 |
| ES2222832A1 (es) | 2005-02-01 |
| CA2533970A1 (en) | 2005-02-17 |
| NO20060682L (no) | 2006-02-10 |
| IL172894A0 (en) | 2006-06-11 |
| NZ545301A (en) | 2008-05-30 |
| RU2006105777A (ru) | 2007-09-20 |
| US7462640B2 (en) | 2008-12-09 |
| ATE432701T1 (de) | 2009-06-15 |
| ES2327845T3 (es) | 2009-11-04 |
| US20070043041A1 (en) | 2007-02-22 |
| ES2222832B1 (es) | 2006-02-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE432701T1 (de) | Indol-6-sulfonamid-derivate, ihre herstellung und ihre verwendung als 5-ht-6 modulatoren | |
| DE50311318D1 (de) | Neue substituierte imidazo-pyridinone und imidazo-pyridazinone, ihre herstellung und ihre verwendung als arzneimittel | |
| DE602006013878D1 (de) | Heterocyclische verbindungen, ihre herstellung und ihre verwendung als antibakterielle mittel | |
| DE602005019743D1 (de) | Oxopiperidinderivate, ihre herstellung und therapeutische verwendung | |
| ATE502035T1 (de) | 2-amido-4-phenylthiazol-derivate, ihre herstellung und ihre therapeutische verwendung | |
| DE502005002105D1 (de) | 4-benzimidazol-2-yl-pyridazin-3-on-derivative, ihre herstellung und verwendung in arzneimitteln | |
| DE602005006815D1 (de) | 2-carbamid-4-phenylthiazol-derivate, deren herstellung und therapeutische verwendung | |
| DE602004021384D1 (de) | Indol-5 -sulfonamid-derivate, ihre herstellung und verwendung als 5-ht-6 modulatoren | |
| DE50312295D1 (de) | 8-ä3-amino-piperidin-1-ylü -xanthine, deren herstellung und deren verwendung als arzneimittel | |
| ATE467633T1 (de) | 2-aryl-6-phenylimidazoä1,2-aüpyridin-derivate, ihre herstellung und therapeutische verwendung | |
| DE602005002470D1 (de) | 1-aminophthalazinderivate, deren herstellung und deren therapeutische verwendung | |
| ATE479437T1 (de) | Benzoä4,5üthienoä2,3-düpyrimidin-4-one und ihre therapeutische verwendung | |
| ATE451923T1 (de) | N-(arylalkyl)-1h-pyrrolopyridin-2-carboxamid- derivate, ihre herstellung und verwendung | |
| ATE417846T1 (de) | Aminotropanderivate, deren herstellung und deren therapeutische verwendung | |
| ATE362469T1 (de) | 2,7-disubstituierteindole und ihre verwendung als 5-ht6 modulatoren | |
| ATE396994T1 (de) | 3-phenylpyridoindolderivate, ihre herstellung und verwendung | |
| DE602006002887D1 (de) | Tricyclische azolderivate, ihre herstellung und ihre verwendung als pharmazeutische mittel | |
| DE602006016258D1 (de) | 4h-1,2,4-triazin-5-on-derivate, ihre herstellung und ihre verwendung als alpha-7-nikotin-acetylcholin-rezeptoren | |
| DE602006015675D1 (de) | 6-heteroarylpyridoindolon-derivate, ihre herstellung und ihre therapeutische anwendung | |
| DE602004015600D1 (de) | Neue imidazolderivative, deren herstellung und deren verwendung als medikament | |
| DE60311598D1 (de) | Naphthyridin-derivate und ihre verwendung als fungizide | |
| ATE484503T1 (de) | 2-pyrrolidin-2-yl-ä1,3,4ü -oxadiazol-derivate und ihre verwendung als antidepressiva | |
| DE602004021383D1 (de) | Indol-7 -sulfonamid-derivate, ihre herstellung und verwendung als 5-ht-6 modulatoren | |
| ATE411295T1 (de) | 2h- oder 3h-benzoäeüindazol-1-yl-karbamat- derivate, herstellung und therapeutische verwendung | |
| DE602004024538D1 (de) | Sulphonamid benzoxazinonderivate. ihre herstellung und verwendung als medikamente |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8364 | No opposition during term of opposition |